![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 27, 25697-25705, July 8, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶
**
From the
Departments of
Physiology and Biophysics
and ||Molecular Genetics and Microbiology, Stony
Brook University, Stony Brook, New York 11794-8661
Substituting alanine for glycine at position 60 in v-H-Ras generated a dominant negative mutant that completely abolished the ability of v-H-Ras to transform NIH 3T3 cells and to induce germinal vesicle breakdown in Xenopus oocytes. The crystal structure of the GppNp-bound form of RasG60A unexpectedly shows that the switch regions adopt an open conformation reminiscent of the structure of the nucleotide-free form of Ras in complex with Sos. Critical residues that normally stabilize the guanine nucleotide and the Mg2+ ion have moved considerably. Sos binds to RasG60A but is unable to catalyze nucleotide exchange. Our data suggest that the dominant negative effect observed for RasG60A·GTP could result from the sequestering of Sos in a non-productive Ras-GTP-guanine nucleotide exchange factor ternary complex.
Received for publication, February 28, 2005 , and in revised form, April 19, 2005.
The atomic coordinates and structure factors (codes 1XJ0 and 1XCM for RasG60A in the GDP- and GppNp-bound forms, respectively) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
* This work was supported in part by National Science Foundation Grant MCB-0316600, the Philip Morris Research Management Group, and an Innovative Technology Development grant (to N. N.). The National Synchrotron Light Source is supported by the Department of Energy and National Institutes of Health, and beamline X26C is supported in part by Stony Brook University and its Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a Medical Scientist Training Grant.
¶ Supported by National Research Service Award T32-DK07521-16 funded by the NIDDK, National Institutes of Health.
** To whom correspondence should be addressed: Dept. of Physiology and Biophysics, Basic Sciences Tower, Stony Brook University, Stony Brook, NY 11794-8661. Tel.: 631-444-3521; Fax: 631-444-3432; E-mail: nicolas.nassar{at}sunysb.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L.-J. Min, M. Mogi, J. Iwanami, J.-M. Li, A. Sakata, T. Fujita, K. Tsukuda, M. Iwai, and M. Horiuchi Angiotensin II Type 2 Receptor Deletion Enhances Vascular Senescence by Methyl Methanesulfonate Sensitive 2 Inhibition Hypertension, May 1, 2008; 51(5): 1339 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Owen, L. J. Campbell, K. Littlefield, K. A. Evetts, Z. Li, D. B. Sacks, P. N. Lowe, and H. R. Mott The IQGAP1-Rac1 and IQGAP1-Cdc42 Interactions: INTERFACES DIFFER BETWEEN THE COMPLEXES J. Biol. Chem., January 18, 2008; 283(3): 1692 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Lapik, J. M. Misra, L. F. Lau, and D. G. Pestov Restricting Conformational Flexibility of the Switch II Region Creates a Dominant-Inhibitory Phenotype in Obg GTPase Nog1 Mol. Cell. Biol., November 1, 2007; 27(21): 7735 - 7744. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |